Suguru Odajima

4PUBLICATIONS
42CO-AUTHORS
Predictive and prognostic markersTraditional Chinese medicine and treatments
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 30, 2026
Neoadjuvant Olaparib and Pembrolizumab Combination Therapy in the Treatment of Patients with HRD-Positive Advanced Ovarian Cancer: A Pilot Study.

|Oct 24, 2023
Short- and long-term morbidity of total parietal peritonectomy for advanced ovarian cancer.

Suguru Odajima, Hiroshi Tanabe, Yuki Koike

Pageof 1